Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All ibuprofen studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchIbuprofenIbuprofen (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 79% Improvement Relative Risk Ibuprofen for COVID-19  Kalayan et al.  LATE TREATMENT Is late treatment with ibuprofen + alkalinization beneficial for COVID-19? Retrospective 99 patients in Argentina (June - September 2020) Lower mortality with ibuprofen + alkalinization (p=0.00092) c19early.org Kalayan et al., European J. Respirator.., Dec 2022 Favors ibuprofen Favors control

Safety and Efficacy of Nebulised Anti-Inflammatory Solution of Alkaline Hypertonic Ibuprofen (AHI) for Treatment of SARS-Cov-2 Infection: A Compassionate Study with a Comparator Arms

Kalayan et al., European Journal of Respiratory Medicine, doi:10.31488/EJRM.132
Dec 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Retrospective 99 COVID-19 patients in Argentina showing significantly lower mortality with inhaled alkaline hypertonic ibuprofen (AHI) treatment. The treatment has a pH of 8.5. 3 times daily for 7-10 days.
2 studies use direct respiratory tract administration Kalayan, Salva
Targeted administration to the respiratory tract provides treatment directly to the typical source of initial SARS-CoV-2 infection and replication, and allows for rapid onset of action, higher local drug concentration, and reduced systemic side effects (early treatment may be more beneficial).
This study is excluded in meta analysis: combined treatments may contribute more to the effect seen.
Study covers ibuprofen and alkalinization.
risk of death, 79.1% lower, RR 0.21, p < 0.001, treatment 3 of 37 (8.1%), control 24 of 62 (38.7%), NNT 3.3.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kalayan et al., 31 Dec 2022, retrospective, Argentina, peer-reviewed, 10 authors, study period June 2020 - September 2020, this trial uses multiple treatments in the treatment arm (combined with alkalinization) - results of individual treatments may vary.
This PaperIbuprofenAll
Safety and Efficacy of Nebulised Anti-Inflammatory Solution of Alkaline Hypertonic Ibuprofen (AHI) for Treatment of SARS-Cov-2 Infection: A Compassionate Study with a Comparator Arms
Galia Kalayan, Ana Carolina Arias Cau, Manuela Del Valle Cabello, Mariela Nuñez, Romina Lumetto, Nicolas Martinez Rios, Luis Argarañas, Néstor García, Roxana Alasino, Dante Beltramo, Roxana Dra, Pabellón Alasino, Ceprocor
European Journal of Respiratory Medicine, doi:10.31488/ejrm.132
Background. This retrospective study evaluates the efficacy of inhalation therapy with alkaline hypertonic ibuprofen (AHI) in COVID-19 positive patients compared to a control group of patients who received conventional treatment. The study was carried out at the Orías Hospital in Jujuy Province, Argentina, from June to September 2020, with final follow-up on September 30. Methods. The study included 99 COVID-19 positive patients with moderate to severe disease (respiratory distress and/or hypoxemia). The control group of 62 patients were treated with the protocols in force at that time, oxygen, dexamethasone and enoxaparin. The group under evaluation comprised 37 patients treated with AH), in addition to standard treatment. Findings. Result shows that the treatment with AHI formulation is safe and effective. The mean respiratory rate (RR) of the patients went from 26.3 before treatment with AHI to 19.8 after treatment. On the other hand, the O2 saturation of patients before treatment with AHI showed a mean of 89.0%; at the end of treatment, the mean was 95.8%. In patients treated with AHI, on day 14, 85% had been discharged, while in patients not treated with AHI, only 36-37% were discharged on day 23. Patients with standard treatment, without AHI, show a mortality of 38.7%, distributed evenly in the 25 days of hospitalization. The mortality of patients treated with AHI was 8.1%, observed within the first 10 days of hospitalization. Interpretation. Results show that nebulization with AHI is an anti-inflammatory therapeutic alternative for the treatment of COVID-19 positive patients.
Declaration of Interests There are no conflicts of interest of the participants of this work to declare. Contributorship Statement Galia Kalayan coordinated the development and data collection; Ana Carolina Arias Cau, Manuela del Valle Cabello, Mariela Nuñez, Romina Lumetto were the ones who collected the data and made their selection; Dante Beltramo, Roxana Alasino, Luis Argañaras, Néstor García and Nicolás Martinez Rios had the idea for the article; Dante Beltramo and Roxana Alasino wrote the article.
References
Beigel, Tomashek, Dodd, Remdesivir for the treatment of Covid-19-Preliminary Report, New Engl J Med, doi:10.1056/NEJMoa2007764
Cao, Wnag, Wen, A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, doi:10.1056/NEJMoa2001282
Capellini, Restini, Bendhack, The Effect of Extracellular pH Changes on Intracellular pH and Nitric Oxide Concentration in Endothelial and Smooth Muscle Cells from Rat Aorta, PlosOne, doi:10.1371/journal.pone.0062887
Cavalcanti, Zampieri, Rosa, Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19, New Engl J Med, doi:10.1056/NEJMoa2019014
Clemente, Freiberger, Ravetti, An in silico analysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease, J Biomo Structure & Dynamics, doi:10.1080/07391102.2021.1872420
Elizur, Cannon, Ferkol, Airway inflammation in Cystic Fibrosis, Chest, doi:10.1378/chest.07-1631
Fang, Jiang, Su, The role of NO in COVID-19 and potential therapeutic strategies, Free Radic Biol Med
Freedman, Loscalzo, Nitric oxide and its relationship to thrombotic disorders, Journal of Thrombosis and Haemostasis
García, Porta, Alasino, Ibuprofen, a traditional drug that may impact the course of COVID-19 New effective formulation in nebulizable solution, Medical Hypotheses
Group, Horby, Estcourt, Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, medRxiv, doi:10.1101/2021.03.09.21252736
Horby, Lim, Dexamethasone in Hospitalized Patients with Covid-19, N Engl J Med, doi:10.1056/NEJMoa2021436
Huang, Lin, Chou, Ibuprofen protects ventilator-induced lung injury by downregulating Rho-kinase activity in rats, BioMed Res Int, doi:10.1155/2014/749097
Jiménez, Martin, Pozo, Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins, Dig Dis Sci, doi:10.1023/a:1013203217788
Landray, Recovery, Randomised Evaluation of COVID-19 therapy) Colchicine arm stopped for lack of efficacy in patients hospitalised with COVID-19
Li, Song, Li, Ibuprofen attenuates interleukin-1β-induced inflammation and actin reorganization via modulation of RhoA signaling in rabbit chondrocytes, Acta Biochim Biophys Sin, doi:10.1093/abbs/gmz101
Li, Zhang, Hu, Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 -A Randomized Clinical Trial, JAMA, doi:10.1001/jama.2020.10044
Libster, Marc, Wappner, Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults, N Engl J Med, doi:10.1056/NEJMoa2033700
Menzel, Kolarz, Modulation of nitric oxide synthase activity by ibuprofen, Inflammation, doi:10.1023/a:1027374605731
Monk, Marsden, Tear, Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, Lancet Respir Med, doi:10.1016/S2213-2600(20)30511-7
Muñoz, Alasino, Garro, High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens, Pharmaceuticals
Onischuk, Tolstikova, An´kov, Ibuprofen, Indomethacin and Diclofenac Sodium Nanoaerosol: Generation, Inhalation Delivery and Biological Effects in Mice and Rats, Journal of Aerosol Science, doi:10.1016/j.jaerosci.2016.05.005
Onischuk, Tolstikova, Sorokina, Analgesic Effect from Ibuprofen Nanoparticles Inhaled by Male Mice, J Aerosol Med Pulmonary Drug Delivery, doi:10.1089/jamp.2008.0721
Pan, Peto, Henao-Restrepo, Repurposed Antiviral Drugs for Covid-19 -Interim WHO Solidarity Trial Results, N Engl J. Med, doi:10.1056/NEJMoa2023184
Perlman, Malik, Ibuprofen prevents thrombin-induced lung vascular injury: mechanism of effect, The Am Physiol Soc. www.physiology.org/journal/ajpheart at Midwestern Univ Lib
Salva Oscar, Roxana, Celia, Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects, Platelets, doi:10.1080/09537104.2021.1967918.-2021
Salva, Doreski, Rersal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program, Infect Dis Ther, doi:10.1007/s40121-021-00527-2
Simonovich, Pratx, Scibona, Plasmar, Group, A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia, N Engl J Med, doi:10.1056/NEJMoa2031304
Veljkovic, Vergara-Alert, Egalés, Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target
Villanueva, Heckenberger, Strobach, Equipotent inhibition by R(-), S(+) and racemic ibuprofen of human polymorphonuclear cell function in vivo, Br J Clin Pharmacol
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, doi:10.1001/jama.2020.1585
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, doi:10.1001/jama.2020.2648
{ 'DOI': '10.31488/ejrm.132', 'ISSN': ['2633-7452'], 'URL': 'http://dx.doi.org/10.31488/EJRM.132', 'container-title': 'European Journal of Respiratory Medicine', 'container-title-short': 'Eur J Respir Med', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': { 'date-parts': [[2022, 11, 22]], 'date-time': '2022-11-22T17:34:40Z', 'timestamp': 1669138480000}, 'deposited': { 'date-parts': [[2022, 11, 22]], 'date-time': '2022-11-22T17:34:46Z', 'timestamp': 1669138486000}, 'indexed': {'date-parts': [[2024, 1, 20]], 'date-time': '2024-01-20T12:21:10Z', 'timestamp': 1705753270789}, 'is-referenced-by-count': 2, 'issue': '2', 'issued': {'date-parts': [[2022]]}, 'journal-issue': {'issue': '2', 'published-online': {'date-parts': [[2022]]}}, 'member': '16388', 'original-title': [], 'prefix': '10.31488', 'published': {'date-parts': [[2022]]}, 'published-online': {'date-parts': [[2022]]}, 'publisher': 'MAK Periodical Library', 'reference-count': 0, 'references-count': 0, 'relation': {}, 'resource': { 'primary': { 'URL': 'https://europeanjournalofrespiratorymedicine.com/safety-and-efficacy-of-nebulised-anti-inflammatory-solution-of-alkaline-hypertonic-ibuprofen-ahi-for-treatment-of-sars-cov-2-infection-a-compassionate-study-with-a-comparator-arms'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['General Medicine'], 'subtitle': [], 'title': 'Safety and Efficacy of Nebulised Anti-Inflammatory Solution of Alkaline Hypertonic Ibuprofen ' '(AHI) for Treatment of SARS-Cov-2 Infection: A Compassionate Study with a Comparator Arms', 'type': 'journal-article', 'volume': '4'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit